Precision Oncology

Your Trusted Partner in Precision Diagnostics

Connect with us

Fortrea has a comprehensive understanding of the diagnostic process, from analytical validation to clinical implementation.

Strategic Regulatory Support

Knowledgeable Diagnostics Global Project Team

Extensive expertise in In Vitro Diagnostics (IVD) Development, Drug-Device Development, Companion Diagnostics (CDx), and Imaging Diagnostics

Evolution of Liquid Biopsies in Clinical Practice

Video

A New Era of Precision Oncology

Liquid biopsies have evolved from a niche diagnostic tool to a versatile instrument in cancer care. Watch this video to learn about its applications and future of this application.

WATCH NOW

Fortrea’s precision oncology experts, part of our Diagnostic Center of Excellence provide the guidance and infrastructure you need to support your liquid biopsy trials.

A New Approach for Diagnostic Development

Successful healthcare product development hinges on innovation to make a real impact.

At Fortrea, we use this philosophy to develop the strategies and designs needed by our stakeholders we collaborate with.

Fortrea combines specialism in.

Regulatory strategy and regulatory affairs
Data management and Quality Systems
Health Economics, Outcomes and Reimbursement (HEOR)
Tokenization
Pre-clinical (non-clinical) testing, rational clinical trial design and conduct, ease of use, training and adoption

Oncology diagnostic data experience

24 Studies

549 Sites

95,094 Subjects

Diagnostic Center of Excellence Team

Khaled Tolba MD, MBBS Senior Medical Director (Oncology)

Laura Vidal, MD Vice President, Therapeutic Strategy Leader (Oncology)

Lisa Moore, PhD RN Executive Director, Medical Device and Diagnostics

Isagani Chico Vice President, Therapeutic area (Oncology)

Mauricio Scarcello, MBA Director, Strategic Delivery & Growth

Ken Morrison Global Head, Oncology Strategy and Planning

Shanthi Sundaramoorthy PhD Senior Director, Strategic Delivery & Growth (Oncology)

Cori Ragan Director, Regulatory and Quality Senior Principal Advisor, Medical Device and Diagnostics

Jason Retzlaff Regulatory/Quality Systems Senior Specialist, Medical device and Diagnostics

Luca Cantini, MD, PhD Medical Director

Paulo Nunes, MSc, MD Medical Director

Yulianna Tymovska, MD, PhD Senior Medical Director

Maria Elvira Parellada Medical Director, Oncology – Hematologic Malignancies

Moez Benali, MD Senior Medical Director

Meet the full team

Discover the Depth of Fortrea Oncology

Explore how our oncology expertise spans the full spectrum—from biomarker-driven precision medicine to immunotherapies, targeted treatments, and advanced cell and gene therapies.

Discover Fortrea Oncology

Insights

Get the latest updates from our Diagnostics Center of Excellence

Blog

Detecting the Undetectable: The Rising Potential of Liquid Biopsies in Oncology

In the past decade, a vial of blood has become a powerful window into cancer biology. Liquid biopsies, once limited to detecting specific mutations in advanced lung cancer, now offer a dynamic, real-time view of tumor genetics across multiple cancer types.

White Paper

The importance of early integration of liquid biopsy to enhance oncology research

Download White Paper

Blog

Future directions in liquid biopsy technology

Recent technological advancements have dramatically improved the sensitivity of liquid biopsies, enabling earlier diagnosis, precise treatment selection and enhanced disease monitoring.